Sera Prognostics, Inc. financial data

Symbol
SERA on Nasdaq
Industry
Services-Medical Laboratories
Location
2749 E. Parleys Way, Suite 200, Salt Lake City, UT
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 222 % -53.7%
Debt-to-equity 40.1 % +120%
Return On Equity -51.7 % -17.5%
Return On Assets -36.9 % +0.86%
Operating Margin -38.4K % -206%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 91.7M USD +134%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 33.5M shares +7.15%
Weighted Average Number of Shares Outstanding, Diluted 33.5M shares +7.15%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 94K USD -71.5%
Research and Development Expense 15.5M USD +4.53%
Selling and Marketing Expense 4.81M USD -52.4%
General and Administrative Expense 15.8M USD -4.7%
Operating Income (Loss) -36.1M USD +12.9%
Nonoperating Income (Expense) 3.85M USD +13.5%
Net Income (Loss) Attributable to Parent -32.2M USD +15.3%
Earnings Per Share, Basic -0.99 USD/shares +18.9%
Earnings Per Share, Diluted -0.99 USD/shares +18.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.68M USD -72.2%
Marketable Securities, Current 47.1M USD +29.1%
Accounts Receivable, after Allowance for Credit Loss, Current 79K USD -49%
Assets, Current 51.1M USD +7.49%
Operating Lease, Right-of-Use Asset 759K USD -42.3%
Other Assets, Noncurrent 1.88M USD +34.7%
Assets 79M USD -12.3%
Accounts Payable, Current 1.38M USD +17.1%
Contract with Customer, Liability, Current 20.2M USD +124%
Liabilities, Current 24.2M USD +78.5%
Operating Lease, Liability, Noncurrent 165K USD -79.2%
Liabilities 24.4M USD +66.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 292K USD
Retained Earnings (Accumulated Deficit) -271M USD -13.5%
Stockholders' Equity Attributable to Parent 54.7M USD -27.5%
Liabilities and Equity 79M USD -12.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.99M USD
Net Cash Provided by (Used in) Financing Activities 1.05M USD
Net Cash Provided by (Used in) Investing Activities -5.69M USD -345%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.68M USD -72.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 9K USD -43.8%
Deferred Tax Assets, Valuation Allowance 64.9M USD +19%
Deferred Tax Assets, Gross 65.2M USD +18.7%
Operating Lease, Liability 792K USD -41.6%
Payments to Acquire Property, Plant, and Equipment 15K USD -61.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -31.3M USD +16.5%
Lessee, Operating Lease, Liability, to be Paid 827K USD -43.7%
Operating Lease, Liability, Current 627K USD +11.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year One 666K USD +3.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 35K USD -69.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 53.1M USD +13.7%
Unrecognized Tax Benefits 2.57M USD +26.9%
Operating Lease, Payments 643K USD +2.55%
Additional Paid in Capital 326M USD +3.36%
Depreciation, Depletion and Amortization 876K USD +5.8%
Deferred Tax Assets, Net of Valuation Allowance 310K USD -27.7%
Share-based Payment Arrangement, Expense 6.74M USD +28%
Interest Expense 5K USD -64.3%